About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNANCT06791590

Evaluating the Effects of Intermittent Oro-esophageal in Tracheotomy Patients With Neurogenic Dysphagia

Neurogenic dysphagia refers to swallowing disorders caused by the damage of swallowing central or peripheral nerves and muscles. According to statistics, about 50% of patients with neurological diseas...

Lead sponsor: Capital Medical University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Capital Medical University

Age

18 - 92 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of neurogenic dysphagia；
•Acute phase has passed, weaning time \> 48 hours, tracheotomy time \>1 week; in accordance with the decannulation process of tracheotomy patients formulated by our center in 2018;
•steady vital signs, without severe cognitive impairment or sensory aphasia, able to cooperate with the assessment；
•Gastrointestinal motility is good, can tolerate more than 150ml/h feeding pump speed;
•Willing to sign an informed consent form.

Exclusion Criteria

•Structural swallowing disorders, such as oral, pharyngeal, larynx, esophagus and other anatomical abnormalities caused by swallowing disorders;
•The clinical condition was unstable, accompanied by heart, lung, brain and other important organ dysfunction;
•Severe cognitive dysfunction, confusion, unable to cooperate.

Related studies

Study on the Correlation Mechanism and Application of Genetic Susceptibility, Hemoglobin Adaptation Changes, and Extubation Success Rate in Stroke Patients With Tracheotomy at Different Altitudes

NCT07014501 · Stroke, Tracheotomy Patients

Not Yet RecruitingNA

Feasibility and Safety of the Airway Exchange Broncholaryngoscope (AEBLScope)

NCT07033702 · Tracheotomy Patients, Airway Management, and more

Dysphagia Symptom Severity and Quality of Life

NCT03241615 · Neurogenic Dysphagia

Findings and Side-effects of Flexible Endoscopic Evaluation of Swallowing - the FEES-Registry

NCT03037762 · Neurogenic Dysphagia, Flexible Endoscopic Evaluation of Swallowing

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 24, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment140

Start dateJan 2025

Last updatedJan 24, 2025

Condition

Neurogenic Dysphagia Tracheotomy Patients

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 24, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions